MedPath
NMPA Product

Pertuzumab Injection

Product approved by National Medical Products Administration (CN)

Basic Information

Pertuzumab Injection

帕妥珠单抗注射液

帕乐坦

420mg(14ml)/瓶

注射剂

Regulatory Information

国药准字S20240054

Approved

生物制品

December 17, 2024

Company Information

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath